Download Free Sample
captcha refresh

Catheter Securement Device Market Size, Share, Growth, and Industry Analysis, By Type (General Surgery, Cardioascular Procedures, Respiratory Procedures, Urological Procedures, Gastric and Oropharyngeal Procedures, Radiology, Other), By Application (Hospitals, Emergency Clinics, Home Healthcare Proiders, Diagnostic Centers), Regional Insights and Forecast to 2035

Catheter Securement Device Market Overview

The global Catheter Securement Device Market size estimated at USD 1096.78 million in 2026 and is projected to reach USD 1635.15 million by 2035, growing at a CAGR of 4.54% from 2026 to 2035.

Catheter securement device market demand continues to expand because healthcare providers increasingly focus on preventing catheter-related complications, reducing accidental dislodgement, and improving patient safety across acute and long-term care settings. More than 300 million peripheral intravenous catheters are inserted annually in the United States, while over 5 million central venous catheters are placed every year. Clinical evidence indicates that catheter stabilization devices can reduce catheter movement by over 70%, supporting improved dwell time and fewer replacement procedures. Hospitals increasingly adopt adhesive securement systems, engineered stabilization platforms, and antimicrobial securement technologies to comply with infection prevention protocols.

Healthcare institutions are also replacing conventional adhesive tape with advanced catheter securement devices because unplanned catheter removal affects nearly 25% of peripheral intravenous lines in several clinical settings. Securement products compatible with ultrasound-guided vascular access are gaining wider adoption as ultrasound-guided procedures exceed 80% in many tertiary hospitals. Silicone-based adhesives, breathable dressings, and skin-friendly materials improve patient comfort while reducing skin injuries among elderly populations. More than 6,000 hospitals worldwide continue expanding vascular access safety programs, supporting sustained procurement of catheter stabilization products.

Peripheral intravenous catheter management remains a major priority across the United States, where approximately 90% of hospitalized patients receive at least one vascular access device during treatment. More than 6,100 hospitals operate nationwide, creating substantial demand for catheter securement devices in emergency departments, operating rooms, oncology centers, and intensive care units. Healthcare facilities increasingly implement standardized catheter stabilization protocols after studies demonstrated reductions exceeding 50% in accidental catheter dislodgement when engineered securement devices replace traditional tape.

The United States continues investing in vascular access improvement programs supported by expanding outpatient infusion services and home healthcare adoption. More than 56 million adults are aged 65 years or older, increasing demand for long-term catheter management solutions because older patients frequently require repeated intravenous therapy. Ambulatory surgery centers performing over 23 million procedures annually increasingly utilize catheter securement devices to reduce replacement frequency and improve procedural efficiency.

Global Catheter Securement Device Market Size,

Key Findings

  • Key Market Driver: Hospitals increased standardized securement adoption by 68% through infection prevention initiatives improving catheter stability nationwide.
  • Major Market Restraint: Skin sensitivity affected 19% of patients limiting adhesive securement acceptance across healthcare facilities globally.
  • Emerging Trends: Silicone adhesive utilization expanded by 42% supporting improved patient comfort and extended catheter stabilization performance.
  • Regional Leadership: North America maintained 39% market share through advanced vascular access practices and clinical guideline adoption.
  • Competitive Landscape: Leading manufacturers controlled 58% combined market presence through diversified securement technology portfolios and innovation.
  • Market Segmentation: Peripheral procedure applications represented 61% utilization supporting consistent demand across multiple healthcare environments worldwide.
  • Recent Development: Antimicrobial securement product launches increased by 31% enhancing infection prevention across modern catheter management practices.

The catheter securement device market is witnessing increasing adoption of integrated stabilization systems designed to reduce catheter migration while improving patient comfort. Silicone adhesive technologies now account for approximately 35% of newly introduced securement products because they minimize medical adhesive-related skin injuries. Healthcare organizations increasingly replace conventional tape with engineered stabilization devices after multiple clinical evaluations demonstrated catheter failure reductions exceeding 45%. Transparent securement dressings with antimicrobial protection continue expanding across intensive care units, while disposable stabilization platforms improve workflow efficiency during vascular access procedures.

Manufacturers are introducing securement devices compatible with ultrasound-guided vascular access, peripherally inserted central catheters, urinary catheters, arterial catheters, and enteral feeding tubes. Digital patient monitoring systems integrated with catheter management protocols have improved compliance rates by approximately 27% in several healthcare organizations. Sustainable manufacturing also influences product development, with recyclable packaging adoption exceeding 30% among major medical device suppliers. Pediatric and neonatal securement devices featuring skin-friendly adhesives continue gaining attention because neonatal skin thickness remains significantly lower than adult skin thickness.

Catheter Securement Device Market Dynamics

DRIVER

"Rising demand for infection prevention and vascular access safety."

Healthcare providers increasingly prioritize catheter stabilization because catheter movement directly contributes to bloodstream infections, therapy interruptions, and repeated insertions. More than 250 million vascular access procedures occur annually worldwide, supporting sustained demand for engineered securement products. Evidence indicates securement devices reduce accidental catheter removal by over 50%, lowering nursing intervention requirements and improving treatment continuity. Growing hospitalization rates, increasing cancer therapies, expanding dialysis procedures, and rising intensive care admissions continue strengthening utilization. Hospitals implementing standardized vascular access protocols report improved catheter dwell time and reduced replacement frequency.

RESTRAINT

"Skin complications associated with adhesive materials."

Despite technological improvements, adhesive-related skin injuries remain an important challenge, particularly among neonatal, pediatric, geriatric, and chronically ill patients. Clinical observations indicate approximately 15% of vulnerable patients experience some level of adhesive-related irritation during prolonged catheter therapy. Premium engineered stabilization products also require greater procurement budgets than conventional adhesive tape, slowing adoption within resource-constrained healthcare facilities. Product standardization varies among institutions, resulting in inconsistent purchasing decisions and clinical preferences.

OPPORTUNITY

"Expansion of home healthcare and outpatient infusion services."

Home healthcare continues expanding because chronic disease treatment increasingly shifts beyond traditional hospital environments. More than 65 million patients receive home healthcare services annually across developed healthcare systems, increasing demand for securement devices designed for prolonged wear and patient mobility. Manufacturers are introducing breathable adhesives, antimicrobial stabilization products, and flexible fixation systems supporting extended catheter dwell times. Portable infusion therapy adoption continues increasing among oncology, antibiotic therapy, and nutrition support patients.

CHALLENGE

"Rising regulatory expectations and product validation requirements."

Medical device manufacturers must satisfy increasingly rigorous clinical validation, biocompatibility testing, and quality assurance standards before commercialization. Regulatory compliance requires extensive product performance documentation, extending development timelines. Hospitals also demand compatibility with multiple catheter sizes, requiring manufacturers to maintain diversified product portfolios. Competition among established suppliers increases pricing pressure while encouraging continuous innovation. Healthcare facilities expect securement devices to provide stronger fixation, easier removal, lower skin trauma, and improved antimicrobial performance simultaneously.

Catheter Securement Device Market Segmentation

The catheter securement device market is segmented by type and application to address diverse clinical requirements. General surgery and cardiovascular procedures generate substantial utilization, while hospitals remain the leading application. Home healthcare and diagnostic centers continue expanding adoption as standardized catheter management protocols improve patient safety and procedural efficiency.

Global Catheter Securement Device Market Size, 2035

BY TYPE

General Surgery: General surgery accounts for approximately 24% of catheter securement device utilization because surgical patients routinely require peripheral intravenous access, urinary catheterization, and postoperative drainage management. More than 310 million surgical procedures are performed globally each year, supporting continuous demand for reliable stabilization products. Advanced adhesive securement devices reduce accidental catheter displacement and improve postoperative recovery efficiency. Healthcare facilities increasingly adopt breathable dressings that minimize moisture accumulation while maintaining secure fixation. Engineered stabilization platforms also reduce dressing replacement frequency and nursing workload. Enhanced infection prevention protocols encourage routine use of antimicrobial-compatible securement products.

Cardiovascular Procedures: Cardiovascular procedures represent approximately 18% of market utilization because catheter stability remains essential during angiography, cardiac interventions, electrophysiology procedures, and postoperative monitoring. More than 7 million cardiac catheterization procedures occur annually worldwide. Securement devices minimize catheter migration during prolonged interventions and intensive monitoring. Hospitals increasingly utilize stabilization products compatible with arterial catheters, central venous catheters, and introducer sheaths. Improved adhesive materials reduce skin trauma while maintaining strong fixation throughout extended cardiac treatment.

Respiratory Procedures: Respiratory procedures contribute nearly 13% of catheter securement device utilization because stabilization remains critical for oxygen therapy, airway management, and intensive respiratory support. More than 390 million individuals worldwide experience chronic respiratory diseases requiring periodic hospital treatment. Securement devices designed for respiratory tubing reduce accidental disconnections while improving patient mobility. Silicone adhesives improve skin compatibility during prolonged ventilation support. Intensive care units increasingly standardize respiratory catheter stabilization protocols after clinical studies demonstrated improved device retention. Healthcare professionals also utilize transparent fixation systems that permit continuous skin inspection. Rising pulmonary disease prevalence strengthens long-term demand for dependable respiratory securement technologies.

Urological Procedures: Urological procedures account for approximately 16% of overall utilization because urinary catheter stabilization reduces accidental dislodgement and improves patient comfort. More than 150 million urinary catheters are used annually worldwide across acute and chronic care settings. Securement devices reduce catheter traction, lowering urethral irritation and patient discomfort. Hospitals increasingly replace adhesive tape with dedicated stabilization systems supporting longer catheter dwell periods. Long-term care facilities and rehabilitation centers continue adopting skin-friendly fixation products for elderly patients.

Gastric and Oropharyngeal Procedures: Gastric and oropharyngeal procedures represent approximately 10% of market demand because enteral feeding tubes require reliable stabilization for nutritional therapy. More than 20 million enteral feeding procedures occur annually worldwide. Securement products minimize accidental feeding tube displacement while improving patient comfort during extended nutritional support. Flexible adhesive technologies reduce facial skin irritation and simplify routine dressing replacement. Pediatric hospitals increasingly adopt specialized feeding tube stabilization products supporting neonatal and infant care.

Radiology: Radiology contributes nearly 11% of catheter securement device utilization because contrast administration requires stable vascular access during diagnostic imaging procedures. More than 80 million computed tomography examinations are conducted annually in the United States alone. Reliable stabilization reduces catheter displacement during patient positioning and imaging workflows. Radiology departments increasingly implement standardized vascular access protocols supporting efficient contrast delivery. Securement devices compatible with power injection systems improve procedural reliability.

Other: Other applications account for approximately 8% of catheter securement device utilization across dialysis, oncology infusion, pediatric care, emergency medicine, and specialty procedures. Dialysis patients undergo approximately 156 treatment sessions annually, requiring dependable vascular access stabilization. Oncology infusion centers increasingly adopt advanced securement devices supporting prolonged chemotherapy administration. Emergency departments prioritize rapid catheter fixation to improve treatment efficiency during critical care. Pediatric healthcare providers utilize soft silicone stabilization products minimizing skin trauma among infants and children.

BY APPLICATION

Hospitals: Hospitals account for approximately 68% of the catheter securement device market because they perform the highest volume of vascular access procedures, surgical interventions, and critical care treatments. More than 6,100 hospitals operate across the United States, while millions of inpatient admissions require intravenous, urinary, arterial, and central venous catheter placement annually. Standardized catheter stabilization protocols reduce accidental dislodgement, improve patient safety, and decrease replacement procedures. Intensive care units, operating rooms, oncology departments, and emergency units increasingly utilize engineered securement devices instead of conventional adhesive tape. Growing infection prevention initiatives and nursing compliance programs continue strengthening product adoption.

Emergency Clinics: Emergency clinics represent approximately 14% of catheter securement device utilization because rapid vascular access is essential during trauma management, emergency surgery, and acute medical treatment. More than 150 million emergency department visits occur annually in the United States, supporting continuous demand for reliable catheter stabilization products. Emergency clinicians require securement systems that provide immediate fixation while allowing quick assessment and replacement when necessary. Breathable adhesive materials improve patient comfort during extended observation periods. Compact stabilization devices simplify emergency workflows while minimizing catheter movement.

Home Healthcare Providers: Home healthcare providers contribute approximately 11% of market demand because long-term infusion therapy, nutritional support, and chronic disease management increasingly occur outside hospitals. More than 65 million patients receive home healthcare services annually across developed healthcare systems. Lightweight securement devices improve patient mobility while maintaining dependable catheter fixation throughout prolonged treatment. Silicone adhesive technologies reduce skin irritation among elderly patients requiring repeated catheter use. Portable infusion pumps and outpatient therapy programs continue expanding demand for durable stabilization products. Healthcare professionals emphasize easy application and painless removal to improve treatment compliance.

Diagnostic Centers: Diagnostic centers account for approximately 7% of catheter securement device utilization because imaging procedures frequently require stable intravenous access for contrast administration. More than 80 million computed tomography examinations are performed annually in the United States, supporting consistent demand for catheter stabilization technologies. Reliable fixation minimizes catheter displacement during patient positioning and imaging procedures. Diagnostic facilities increasingly implement standardized vascular access protocols that improve workflow efficiency and reduce repeat catheter insertions. Transparent securement dressings allow continuous catheter inspection while supporting infection prevention objectives.

Catheter Securement Device Market Regional Outlook

The catheter securement device market demonstrates strong regional variation driven by healthcare infrastructure, procedural volumes, infection prevention standards, and chronic disease prevalence. North America leads global demand, Europe emphasizes clinical guideline compliance, Asia-Pacific records expanding healthcare investment, and Middle East & Africa continue improving access to advanced vascular care technologies.

Global Catheter Securement Device Market Share, by Type 2035

NORTH AMERICA

North America holds approximately 39% of the global catheter securement device market because of advanced healthcare infrastructure, widespread adoption of engineered stabilization devices, and strong infection prevention standards. More than 6,100 hospitals operate within the United States, supporting significant demand across acute and outpatient care settings. Increasing surgical procedures, growing cancer treatment volumes, and expanding home healthcare services strengthen utilization. Hospitals routinely implement standardized vascular access protocols that reduce catheter failure and improve patient safety. Continuous innovation in antimicrobial dressings, silicone adhesives, and integrated stabilization systems further supports regional market leadership while encouraging replacement of conventional adhesive tape with advanced securement technologies.

EUROPE

Europe represents approximately 28% of the catheter securement device market supported by strong regulatory compliance, established public healthcare systems, and evidence-based catheter management guidelines. More than 15 million surgical procedures are conducted annually across major European healthcare systems, increasing demand for dependable catheter stabilization products. Hospitals increasingly utilize antimicrobial dressings and engineered securement devices to reduce catheter-related complications. Aging populations continue increasing long-term vascular access requirements. National infection prevention initiatives encourage standardized catheter care practices throughout hospitals, rehabilitation facilities, and outpatient treatment centers. Continuous clinical education and product innovation strengthen regional adoption of advanced securement technologies.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 24% of global catheter securement device demand because healthcare infrastructure expansion and increasing hospital admissions continue accelerating procedural volumes. The region contains more than 4.7 billion people, creating substantial long-term demand for vascular access management solutions. Rising chronic disease prevalence, increasing surgical procedures, and expanding government healthcare investment support wider adoption of catheter stabilization products. Hospitals increasingly replace conventional adhesive tape with engineered securement systems that improve patient safety and reduce catheter dislodgement. Growth in medical tourism, modern healthcare facilities, and specialized infusion therapy services further strengthens utilization throughout Asia-Pacific healthcare institutions.

MIDDLE EAST & AFRICA

Middle East & Africa contribute approximately 9% of the catheter securement device market as healthcare modernization programs continue expanding access to advanced medical technologies. Increasing hospital construction, rising intensive care capacity, and improved infection prevention practices encourage adoption of engineered catheter stabilization products. More than 500 million people across the region require expanding healthcare infrastructure supporting long-term vascular access management. Government investments in tertiary hospitals and specialized treatment centers improve availability of modern securement technologies. Growing awareness of catheter-related infection prevention, nursing education initiatives, and increased procurement of advanced medical devices continue supporting gradual market expansion.

List of Top Catheter Securement Device Companies

  • 3M Company
  • Braun Melsungen
  • Baxter International
  • R. Bard
  • Centurion Medical Products
  • Conatec
  • C. Johnson Company
  • Medtronic
  • Merit Medical Systems
  • Smiths Group

List of Top 2 Companies Market Share

  • 3M Company – Approximately 18% market share supported by diversified vascular access products, advanced securement technologies, and broad global healthcare distribution.
  • Becton Dickinson (C. R. Bard) – Approximately 16% market share supported by extensive catheter management solutions, strong clinical adoption, and continuous product innovation.

Investment Analysis and Opportunities

Healthcare providers continue increasing investments in catheter securement technologies because preventing catheter-related complications reduces treatment interruptions and improves clinical efficiency. More than 300 million peripheral intravenous catheters are inserted annually in the United States, creating consistent procurement demand for engineered stabilization devices. Hospitals are allocating larger portions of medical device budgets toward antimicrobial dressings, silicone-based adhesives, and integrated catheter securement systems that enhance patient safety. Outpatient infusion centers, ambulatory surgery facilities, and dialysis clinics are also expanding purchases of advanced stabilization products to support growing procedural volumes. Manufacturing investments increasingly focus on automation, precision adhesive coating, and environmentally responsible packaging. Research partnerships between healthcare institutions and medical device manufacturers continue accelerating product validation and clinical adoption while strengthening long-term investment potential across mature and emerging healthcare markets.

Investment opportunities are expanding through home healthcare, specialty infusion therapy, pediatric care, and digital vascular access management. More than 65 million patients receive home healthcare services annually across developed healthcare systems, increasing demand for lightweight and skin-friendly securement devices designed for prolonged use. Manufacturers continue investing in antimicrobial technologies, breathable fixation materials, and universal securement platforms compatible with multiple catheter types. Healthcare infrastructure expansion across Asia-Pacific and the Middle East supports additional manufacturing facilities and regional distribution networks. Clinical education programs promoting standardized catheter stabilization practices further improve product adoption. Investors also recognize opportunities in sustainable medical materials, recyclable packaging, and smart monitoring systems that improve catheter maintenance while supporting healthcare quality initiatives.

New Product Development

Product innovation within the catheter securement device market increasingly focuses on improving fixation strength, patient comfort, infection prevention, and compatibility with multiple catheter types. Manufacturers are introducing silicone adhesive technologies that reduce medical adhesive-related skin injuries while maintaining dependable stabilization during extended catheter dwell periods. Antimicrobial securement dressings containing advanced protective materials continue gaining acceptance because they support infection prevention objectives across intensive care units and surgical departments. Transparent stabilization platforms allow continuous visualization of catheter insertion sites, improving routine clinical assessment. More than 80% of newly introduced securement products emphasize skin-friendly materials, simplified application techniques, and compatibility with evidence-based vascular access protocols adopted by modern healthcare facilities.

Development efforts also emphasize sustainability, digital integration, and specialized clinical applications. Manufacturers increasingly design universal stabilization devices suitable for peripheral intravenous catheters, central venous catheters, urinary catheters, arterial catheters, and enteral feeding tubes. Flexible fixation systems improve patient mobility while reducing accidental catheter displacement during routine activities. Recyclable packaging adoption continues increasing as healthcare organizations implement environmental sustainability initiatives. Pediatric and neonatal securement devices receive additional design attention because infant skin requires lower adhesive force and improved flexibility. Continuous laboratory testing, human factors engineering, and clinical validation support product improvements that enhance performance, simplify nursing workflows, and strengthen long-term adoption across hospitals, outpatient facilities, and home healthcare environments.

Five Recent Developments

  • 2023: 3M Company expanded its vascular access portfolio by enhancing catheter securement solutions with improved silicone adhesive technology designed to reduce skin trauma and increase secure fixation during extended catheter use.
  • 2023: Becton Dickinson (C. R. Bard) strengthened vascular access management by introducing updated securement solutions compatible with ultrasound-guided catheter placement, improving procedural efficiency and stabilization performance.
  • 2024: Medtronic advanced catheter stabilization technologies by integrating improved skin-compatible adhesive materials supporting longer catheter dwell time and enhanced patient comfort during clinical treatment.
  • 2024: B. Braun Melsungen expanded production capacity for vascular access products to improve global product availability and support increasing hospital demand for engineered catheter securement devices.
  • 2025: Merit Medical Systems enhanced its securement product portfolio through improved fixation system designs supporting multiple catheter applications while simplifying clinical application and removal procedures.

Report Coverage of Catheter Securement Device Market

The catheter securement device market report provides comprehensive analysis of industry structure, product innovation, application trends, regional performance, competitive landscape, investment opportunities, and technological developments influencing future demand. The report evaluates securement devices utilized across peripheral intravenous catheters, central venous catheters, urinary catheters, arterial catheters, feeding tubes, and specialty vascular access procedures. Market assessment includes utilization across hospitals, emergency clinics, home healthcare providers, and diagnostic centers while highlighting procedural volumes, patient safety initiatives, and infection prevention practices. More than 310 million surgical procedures performed annually worldwide and increasing chronic disease prevalence support detailed evaluation of current market requirements and emerging clinical opportunities.

The report also examines segmentation by procedure type, regional adoption patterns, manufacturing developments, healthcare infrastructure expansion, and competitive positioning of leading industry participants. Detailed assessment covers North America, Europe, Asia-Pacific, and Middle East & Africa, emphasizing healthcare modernization, regulatory compliance, and evolving vascular access standards. Product innovation analysis highlights antimicrobial dressings, silicone adhesive technologies, breathable fixation materials, transparent stabilization systems, and sustainable packaging developments. The report further evaluates investment priorities, research activities, procurement trends, and strategic product development initiatives that influence purchasing decisions across hospitals and outpatient healthcare facilities. Comprehensive coverage supports manufacturers, distributors, healthcare providers, investors, and policymakers seeking data-driven insights into the evolving catheter securement device market.

Catheter Securement Device Market Report Coverage

REPORT COVERAGE DETAILS
Market Size Value In USD 1096.78 Million in 2026
Market Size Value By USD 1635.15 Million by 2035
Growth Rate CAGR of 4.54% from 2026 - 2035
Forecast Period 2026 - 2035
Base Year 2025
Historical Data Available Yes
Regional Scope Global
Segments Covered
By Type General Surgery | Cardioascular Procedures | Respiratory Procedures | Urological Procedures | Gastric and Oropharyngeal Procedures | Radiology | Other
By Application Hospitals | Emergency Clinics | Home Healthcare Proiders | Diagnostic Centers

Frequently Asked Questions

The global Catheter Securement Device Market is expected to reach USD 1635.15 Million by 2035.

The Catheter Securement Device Market is expected to exhibit a CAGR of 4.54% by 2035.

3M Company, Braun Melsungen, Baxter International, C. R. Bard, Centurion Medical Products, Conatec, M. C. Johnson Company, Medtronic, Merit Medical Systems, Smiths Group

In 2026, the Catheter Securement Device Market is estimated at USD 1096.78 Million.

OUR
CLIENTS

Google Bosch Pfizer Sony Deloitte Accenture Dupont BASF Ansell Nvidia Airbus Dell Fresenius Siemens abbott yamaha samsung Duracell novonordisk huawei UPS Deloitte Fresenius yamaha samsung uniliver Amgen Kohler Samyang kaman Gallagher hoerbiger Itochu ITIC kINSEY EY Mitsubishi Staller